Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model

Breast Cancer Research and Treatment

Volumn 114, Issue 2, 2009, Pages 391-

  Hadad, Sirwan M ^a   Appleyard, Virginia ^a   Thompson, Alastair M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ESTROGEN RECEPTOR ALPHA; METFORMIN;

ANGIOGENESIS; BREAST CANCER; CANCER MODEL; ENZYME ACTIVATION; HUMAN; LETTER; PHENOTYPE; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MELANOMA; METFORMIN; MICE; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE;

EID: 59449093294     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0016-3     Document Type: Letter

References (6)

1. Phoenix KN, Vumbaca F, Claffey KP (2008) Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat. doi: 10.1007/s10549-008-9916-5
2. R Cailleau M Olive QV Cruciger 1978 Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization In Vitro 14 11 911 915
3. BR Brinkley PT Beall LJ Wible 1980 Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro Cancer Res 40 9 3118 3129
4. DT Ross U Scherf MB Eisen 2000 Systematic variation in gene expression patterns in human cancer cell lines Nat Genet 24 3 227 233
5. G Ellison T Klinowska RF Westwood 2002 Further evidence to support the melanocytic origin of MDA-MB-435 Mol Pathol 55 5 294 299
6. J Rae C Chad M Jeanne 2007 MDA-MB-435 cells are derived from M14 Melanoma cells-a loss for breast cancer, but a boon for melanoma research Breast Cancer Res Treat 104 1 13 19